Patritumab Deruxtecan in Patients With Solid Tumor Harboring an NRG1 Fusion
Patritumab Deruxtecan in Patients With Solid Tumor Harboring an NRG1 Fusion
Recruiting · NCT06383884 · Registry updated 2025-12-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Patritumab Deruxtecan in Patients With Solid Tumor Harboring an NRG1 Fusion | Solid Tumor, Adult | Recruiting | Phase 2 | 2025-12-15 | NCT06383884 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Samsung Medical Center | 207 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Samsung Medical Center | Seoul | South Korea | 375 |